Parental smoking and middle ear effusions in children

A E Hinton1, G Buckley

  • 1Midland Centre for Neurosurgery and Neurology, Swethurde, Warley, W. Midlands.

Insights

Parental smoking is linked to middle ear effusions in children. Children with abnormal tympanometry results were more likely to have smoking parents, highlighting environmental health risks.

Area of Science:

  • Pediatrics
  • Environmental Health
  • Otolaryngology

Background:

  • Middle ear effusion (MEE) is a common childhood condition.
  • The role of environmental factors, such as parental smoking, in MEE is under investigation.

Purpose of the Study:

  • To determine the association between parental smoking and the presence of middle ear effusions in children.
  • To explore the relationship between parental smoking and the resolution of middle ear effusions.

Main Methods:

  • A study involving seventy children was conducted.
  • Data collection included questionnaires, clinical examinations, and audiological tests, specifically tympanometry.
  • Children were categorized based on the presence or absence of middle ear effusions and tympanometry results.

Main Results:

  • A significant association was found between the presence of middle ear effusions and parental smoking.
  • Children with abnormal tympanometry results were more likely to have at least one parent who smoked.
  • No correlation was observed between the resolution of middle ear effusions and parental smoking status.

Conclusions:

  • Parental smoking is a potential risk factor for the development of middle ear effusions in children.
  • Advising parents on the impact of smoking on their child's ear health and encouraging smoke-free environments is recommended.
  • Further research may explore specific mechanisms linking environmental smoke exposure to MEE pathogenesis.

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Respiratory System Abnormal Finding I: Inspection and Percussion01:30

Respiratory System Abnormal Finding I: Inspection and Percussion

Respiratory system abnormalities are a significant concern in healthcare due to their potential to indicate underlying severe conditions like Chronic Obstructive Pulmonary Disease (COPD), asthma, and pneumonia. These abnormalities can often be detected through physical examination methods like inspection and percussion.
Inspection Findings
During an inspection, several findings may suggest the presence of respiratory distress or disease. Pursed-lip breathing, where exhalation is slowed by...
Respiratory System Abnormal Finding II: Palpation and Auscultation01:31

Respiratory System Abnormal Finding II: Palpation and Auscultation

In assessing respiratory abnormalities, palpation and auscultation are critical tools for detecting and interpreting various pathophysiological changes. These techniques provide insight into underlying disorders by evaluating tactile sensations and sounds produced by the respiratory system.
Palpation Findings
During a respiratory assessment, palpation can reveal several vital abnormalities:
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...